Global PR Summit 2015
The most important event in the global communications world’s calendar.
The key global benchmark of PR agency rankings, industry size and global comms trends.
The most creatively awarded PR campaigns and agencies in the world.
The Holmes Report profiles marketing and communications innovators from across North America and EMEA.
In-depth annual research into the PR industry's efforts to raise creative standards.
Coverage of the World Economic Forum in Davos.
Creative work, trends and views from the global public relations industry.
Dedicated to exploring the new frontiers of PR as it dives deeper into social media, content and analytics.
Our coverage of key technology PR trends and challenges around the world.
From brand marketing to conscious consumerism, coverage of key marketing and PR trends worldwide.
Coverage of healthcare PR and marketing.
Financial communications, sector news and mergers and acquisitions.
Coverage of global corporate reputation and communications news and trends.
The world's biggest PR awards programme, dedicated to benchmarking the best PR work from across the globe.
A high-level forum designed for senior practitioners to address the critical issues facing the profession.
Exploring the innovation and disruption that is redefining influence and engagement.
The Holmes Report's annual selections for PR Agencies of the Year, across all of the world's major markets.
Bringing together in-house comms leaders with PR firms to discuss critical global issues.
Pfizer is reviewing comms support for the spin-off of its animal health business, just days after launching an overall holding company review.
Arun Sudhaman 12 Apr 2012 // 11:00PM GMT
NEW YORK--Pfizer is reviewing comms support for the potential spin-off of its animal health business, shortly after launching an overall holding company review.
The company revealed last year that it is expecting to spin-off of its animal health unit, which is worth an estimated $4bn. To accompany this process, Pfizer has issued a global RFP to a number of holding companies, as it prepares the ground for this outcome.
"In the event Animal Health becomes a separate business from Pfizer, we are currently exploring a range of new branding assets that would be needed to support a separate identity," a Pfizer spokesperson told the Holmes Report. "The scope of this review is global and will take place over the course of the next few weeks."
The RFP follows reports last week that Pfizer has also issued an RFI for the entire company, excluding its animal health and nutrition units, the latter of which is expected to be sold outright. That document has, added the spokesperson, been circulated to "holding companies and key independent agencies", as part of a periodic review of its marketing efforts.
The two reviews are separate. Since taking charge of the company in late 2010, Pfizer CEO Ian Read is attempting to divest the company of non-core businesses, because of a major revenue slump caused by cholesterol blockbuster drug Lipitor coming off patent.
The animal health RFP is understood to include a significant public relations component, incorporating financial communications and change management. Pfizer currently works with a number of PR firms including, in particular, Edelman, Chandler Chicco, Fleishman-Hillard, Ketchum and Weber Shandwick.
Pfizer's animal health business develops products for livestock and pets, and operates in more than 60 countries.
Arun Sudhaman 18 May 2015
Definitive picture of global PR industry emerges today, as the Holmes Report and ICCO launch the 201 ...
Aarti Shah 16 Apr 2015
While women make up about 70% of the PR workforce, they only hold about 30% of the top positions in ...
We feel that the views of the reader are as important as the views of the writer. Please contact us at [email protected]Signup for Newsletter Sitemap
© The Holmes Report 2014